The Office of Biostatistics Research at the National Heart, Lung, and Blood Institute will host a two-day workshop September 18–19 at the Natcher Conference Center on the main campus of the National Institutes of Health in Bethesda, Maryland, and virtually via Zoom.

This workshop will address two main design issues for randomized clinical trials: selection of clinically meaningful endpoints and appropriate futility monitoring.

Topics include the following:

• Statistical methods for endpoint choices
• Endpoints in cardiovascular diseases
• Endpoints in blood and lung diseases
• Logistics for statistical futility monitoring
• Statistical methods for futility monitoring
• Case studies for futility monitoring

Experts from academia, industry, and the US federal government will share their insights and solutions to these issues. The conference should be of particular interest to biostatisticians, clinical trialists, medical researchers, and clinicians.

This workshop is free and open to the public, but registration is required.

For more information, visit the NIH website or email Barbara Bloomquist.